A Role for Non-canonical Wnt/PCP Signaling in Growth and Self-Renewal of Embryonal Rhabdomyosarcoma |
Massachusetts General Hospital / Madeline Hayes, PhD |
Young Investigator Grants |
2016 |
Massachusetts |
A Role for Notch in Self-renewal in Embryonal Rhabdomyosarcoma |
Massachusetts General Hospital / Myron Ignatius, PhD |
'A' Award Grants |
2012 |
Massachusetts |
A Translational Approach to Identify Drugs with Specific Activity Against EZH2 Mutant High Risk T-ALLs and ETP ALLs that Overexpress the JDP2 bZIP Transcription Factor |
Dana-Farber Cancer Institute / Shuning He, PhD |
Young Investigator Grants |
2015 |
Massachusetts |
Aberrant DNA methylation in Ewing sarcoma.
|
Fred Hutchinson Cancer Research Center / Scott Borinstein |
Young Investigator Grants |
2009 |
Washington |
Accelerating Access to Cellular Therapies for the Treatment of Childhood Malignancies |
Seattle Children’s Hospital and Regional Medical Center / Julie Park, MD |
Phase I/II Infrastructure Grants |
2013 |
Washington |
Accessing Combinatorial Effect of PARP Inhibitor with DNA Damaging Agent in Rhabdomyosarcoma at Single Cell Resolution |
Massachusetts General Hospital / Chuan Yan, PhD |
Young Investigator Grants |
2018 |
Massachusetts |
Activating Metabolic Pathways to Increase the Persistence of Leukemia Targeting T Cells |
Children’s Hospital of Pittsburgh / Erica Braverman, MD |
Young Investigator Grants |
2021 |
Pennsylvania |
Adaptation of acute lymphoblastic leukemia (ALL) to the post-transplant allogeneic environment.
|
University of Rochester / Craig Mullen |
Innovation Grants |
2009 |
New York |
Adoptive Cell Therapy Targeting Antigen Escape Variants in Childhood High Grade Glioma |
Baylor College of Medicine / Meenakshi Hegde |
Young Investigator Grants |
2012 |
Texas |
Adoptive Immunotherapy of Tr1 Cells to Improve Outcome of Allo-HSCT Treatment for Pediatric AML |
Stanford University / Maria-Grazia Roncarolo, MD & Rosa Bachetta, MD |
Reach Grants |
2015 |
California |